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http://dx.doi.org/10.1016/j.stemcr.2016.05.002SUMMARYToll-like receptor 4 (TLR4) plays a central role in host responses to bacterial infection, but the precise mechanism(s) by which its down-
stream signaling components coordinate the bone marrow response to sepsis is poorly understood. Using mice deficient in TLR4 down-
stream adapters MYD88 or TRIF, we demonstrate that both cell-autonomous and non-cell-autonomous MYD88 activation are major
causes of myelosuppression during sepsis, while having a modest impact on hematopoietic stem cell (HSC) functions. In contrast,
cell-intrinsic TRIF activation severely compromises HSC self-renewal without directly affecting myeloid cells. Lipopolysaccharide-
induced activation of MYD88 or TRIF contributes to cell-cycle activation of HSC and induces rapid and permanent changes in tran-
scriptional programs, as indicated by persistent downregulation of Spi1 and CebpA expression after transplantation. Thus, distinct
mechanisms downstream of TLR4 signaling mediate myelosuppression and HSC exhaustion during sepsis through unique effects of
MyD88 and TRIF.INTRODUCTION
In the adult, the bone marrow (BM) is the central organ for
blood production, generating a large number of mature
circulating cells daily from a small number of hematopoiet-
ic stem cells (HSC). During bacterial infection, BM HSC are
challenged with the need of expanding progenitor cell
pools to replenish the mature immune cells required to
fight the pathogens, in particular neutrophils. Sepsis is
one of the most dramatic examples of inadequate host
BM response to infection, whereby an initial neutro-
philia and hyper-reactive immune response is followed
by profound neutropenia, leukocyte hyporesponsiveness,
and consequently an inability of the host to control the
bacterial infection (Bosmann and Ward, 2013; Hotchkiss
and Karl, 2003). The incidence of sepsis is rising, due to
increased longevity of patients with chronic diseases and
antibiotic-resistant organisms. Even though significant
efforts have been made to improve treatment of patients
with sepsis, no effective therapy is available and mortality
rates remain very high (28%–50%) (Angus, 2011). Hence,
novel ideas and approaches are sorely needed to address
this significant health problem.
Despite the critical role of the BM during infection, the
contribution of BM failure to morbidity and mortality in
sepsis has not been fully recognized.Mechanism(s) causing
HSC dysfunction in this clinical setting remain elusive. Us-
ing an animalmodel of sepsis and endotoxemia induced by
Pseudomonas aeruginosa or by its lipopolysaccharide (LPS),
we previously demonstrated that HSC act as a direct path-
ogen stress sensor through activation of Toll-like receptor940 Stem Cell Reports j Vol. 6 j 940–956 j June 14, 2016 j ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativ4 (TLR4) (Rodriguez et al., 2009;Weighardt andHolzmann,
2007). In this model, HSC undergo dysfunctional expan-
sion in the BM, which is associated with a block of myeloid
differentiation and neutropenia in a TLR4-dependent
manner. Furthermore, we observed that acute exposure of
HSC to LPS permanently affects their ability to engraft
and self-renew. A subsequent study also showed that
chronic activation of TLR4 impairs HSC functions (Esplin
et al., 2011). Collectively, this indicates a broad role of
TLR4 in the regulation of hematopoietic homeostasis un-
der stress conditions.
TLR4 recognizes the LPS component of Gram-negative
bacteria such as P. aeruginosa, Salmonella, and Escherichia
coli (O’Neill and Bowie, 2007), which account for 60%
of sepsis cases (Vincent et al., 2009). Activation of TLR4
by its ligand LPS sets off intracellular signaling through
two different adaptors: myeloid differentiation factor 88
(MYD88) and TIR-domain-containing adapter-inducing
interferon b (TRIF) (Kawai et al., 2001; Weighardt et al.,
2004). The MYD88-dependent pathway activates nuclear
factor kB (NF-kB) and activator protein 1 (AP-1), in a
manner dependent on mitogen-activated protein kinases
(ERKs1/2, JNK, and p38), converging in pro-inflammatory
programs. On the other hand, the TRIF pathway activates
interferon regulator factor 3 (IRF-3), which induces inter-
feron b (IFN-b) production, also responsible for late activa-
tion of NF-kB (Kawai et al., 2001; Yamamoto et al., 2003).
Genetic targeting of TLR4, MYD88, and TRIF has demon-
strated the complexity of these delicate regulatory path-
ways during immune response, revealing both deleterious
and protective roles of these molecules during severers.
ecommons.org/licenses/by-nc-nd/4.0/).
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bacterial infection. Thus, significant challenges remain for
the therapeutic targeting of TLR4 signaling during sepsis
(Weighardt et al., 2002). TLR4 and its co-receptor MD2
are expressed inHSC (Nagai et al., 2006), but the functional
role of TLR4 downstream signaling inHSC remains unclear.
Although a considerable number of studies have investi-
gated the role of MYD88 or TRIF in response to bacterial in-
fections (Roger et al., 2009), it is largely unknownhow each
pathway affects the function of HSC and progenitors. Hy-
pothesizing that both MYD88 and TRIF are critical during
the BM response against bacterial infections, we deter-
mined their distinct contributions to HSC and progenitor
regulation. We show that during sepsis, MYD88 plays a
dominant role in myelosuppression, whereas TRIF medi-
ates persistent injury to HSC functions. These data provide
insights into how TLR4 and its adaptors control HSC
response to sepsis, thus serving as a guide to define down-
stream molecules that can be independently targeted
to prevent the negative outcomes of severe bacterial
infection.RESULTS
Our previous work showed that severe bacterial sepsis
induced by P. aeruginosa or by its LPS causes a TLR4-depen-
dent dysfunctional expansion of HSC and hematopoi-
etic progenitor cells (HSPC) (Rodriguez et al., 2009). To
determine whether these changes are MYD88 or TRIF
dependent, we performed LPS challenge in mice lacking
MYD88 (MYD88/) or TRIF (TRIF/). Similar to our previ-
ous findings, wild-type (WT) mice responded to LPS with a
significant increase in the frequency and absolute number
of BM LinSCA-1+c-KIT+ (LSK) cells, a subset enriched in
HSPC (4-fold; Figures 1A and 1C). Surprisingly, TRIF/
mice exhibited no such expansion of LSK cells, whereas
MYD88/ mice behaved in a manner similar to WT mice
(Figures 1A and 1C).
The LSK pool can be further dissected by immunopheno-
typic analysis into distinct subsets (Figure 1B) (Kiel et al.,
2005; Wilson et al., 2008), consisting of: long-term HSCs
(LT-HSC; LinSCA-1+c-KIT+CD150+CD48), which have
the ability to self-renew; multipotential progenitor 1 cellsFigure 1. LPS and Sepsis Induce HSC Expansion in a TRIF-Depend
Immunophenotypic analysis of BM cells was conducted by fluorescenc
24 hr after challenge with LPS or PBS, or CLP surgery.
(A and B) Representative contour plots for LSK populations (A)
c-KIT+CD150+CD48; MPP1: LinSCA-1+c-KIT+CD150+CD48+; MPP2: Lin
(C–F) Average frequency of LSK (C), LT-HSC (D), MPP1 (E), and MPP2
number per femur of each subset (right) in PBS- versus LPS-challenge
(G) Average absolute number of cells per femur in CLP-challenged vers
MPP1, and MPP2 (WT: n = 6–11; MYD88/ and TRIF/: n = 3–5).
Data represent mean ± SEM. LPS versus PBS: *p < 0.05, **p < 0.01; W
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short-term HSCs (ST-HSC); and MPP2 cells (LinSCA-1+
c-KIT+CD150CD48+).WTandMYD88/mice responded
to LPS with a noticeable increase in LT-HSC and a robust
expansion (5-fold) of MPP1 and MPP2, in both frequency
and absolute number (Figures 1D–1F). In contrast, TRIF/
mice did not show any noticeable increase in LT-HSC,
MPP1, or MPP2 subsets. Of note, following LPS challenge
the representation of LT-HSC andMPPwithin the LSK pop-
ulation shifted in similar manner in all genotypes, with
increased representation of MPP1 cells at the expense of
LT-HSC (Figure 1B); however, as the total LSK population
dramatically increased in WT and MYD88/ mice, the
LT-HSC frequency in the Lin cell pool and their total abso-
lute number were increased in these genotypes. Overall,
there was a trend for increased absolute numbers of
LT-HSC (LSK CD150+CD48) in WT mice following LPS,
though not statistically significant. Increases in LT-HSC
cell numbers were also observed when CD34 and FLK2
were used to define LT-HSC and ST-HSC (Figure S1A), but
not when a more stringent definition of the LT-HSC pool
was adopted by using SLAM markers in combination with
CD244 and CD229 (Oguro et al., 2013) (Figure S1B).
To determine whether these changes were also seen in a
bacterial sepsis model, we utilized a mouse model of cecal
ligation and puncture (CLP)-induced polymicrobial perito-
nitis (Ferreira et al., 2014). Responses noted in the LPS
modelwere to a large extent recapitulated in theCLPmodel
(Figure 1G). Modest differences between the models are
likely due to the higher complexity of bacterial sepsis
compared with LPS challenge. Collectively, these data
show that both LPS and bacterial sepsis result in a dramatic
increase in MPP1 and MPP2 subsets, associated with no
or modest expansion of LT-HSC, and that TRIF, but not
MYD88, is required for this process.Role of SCA-1 Expression and Cell-Cycle Activation in
LPS-Induced LSK Expansion
Upregulation of stem cell antigen 1 (SCA-1) expression on
HSPC (Essers et al., 2009) and contamination of the LSK
poolwith Linc-KIT+SCA-1 (LK) progenitors re-expressing
SCA-1 have been reported in response to IFN type Ient Manner
e-activated cell sorting (FACS) on WT, MYD88/, and TRIF/mice
or HSPC (B) labeled with SLAM marker (LT-HSC: LinSCA-1+
SCA-1+c-KIT+CD150CD48+).
(F) in the gated Lin population (left) and average absolute cell
d mice (n = 5–14).
us sham-treated mice in BM subsets, from left to right: LSK, LT-HSC,
T versus MYD88/ or TRIF/: p^ < 0.05, ^^ p < 0.01.
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exposure (Pietras et al., 2014). In our study, SCA-1 upregu-
lation following LPS occurred mostly on the MPP (MPP1
and MPP2) subsets, and was observed in WT and
MYD88/ mice, but not in TRIF/ mice (Figure S2A). To
determine whether the LSK expansion observed in our
model was due to Sca-1 re-expression on more committed
progenitors, we tracked the expression of lysozyme-M
(Lys) and FCgR in LSK cells in response to LPS. In Lys-
GFP transgenic mice (Faust et al., 2000), GFP is under
control of the lysozyme promoter, whose activation is
increased during myeloid differentiation. Thus, Lys-GFP
is highly expressed in myeloid progenitors, in particular
in common myeloid progenitor (CMP) and granulocyte-
monocyte progenitor (GMP), whereas its expression ismin-
imal in LSK cells (Miyamoto et al., 2002). Similarly, FCgR is
highly expressed in GMP and myeloid progenitors. We
reasoned that if LSK expansion was due to SCA-1 re-expres-
sion by myeloid progenitors, the LSK subset would show a
dominant representation of Lys-GFP- and FCgR-expressing
cells following LPS challenge. LSK cells from the LPS-chal-
lenged mice (defined hereafter as LPS LSK cells) showed a
higher content of Lys-GFP and FCgR expression compared
with LSK cells from control PBS mice (defined hereafter as
PBS LSK cells), especially in the MPP fraction (Figures 2A,
S2B, and S2C); however, increases in absolute numbers
were modest (Figure 2B). Total numbers of Lys-GFP cells
were reduced within the overall Linc-KIT+ population
(including SCA-1+ and SCA-1 cells) following LPS (Fig-
ure S2D). This is in agreement with our collective observa-
tions that severe sepsis or LPS inhibits differentiation and
reduces output of myeloid cells. Of note, Lys-GFP fluores-
cent intensity was not directly affected by LPS (Figure S2E).
Comparison of FCgR expression in the LSK subsets of WT,
MYD88/, and TRIF/ showed no noticeable differences
among different genotypes (Figure S2F). Taken together,
these data indicate that contamination of the LSK pool
by more differentiated cells re-expressing SCA-1 contrib-
utes only in part to the cell expansion of primitive cells
observed following LPS.
In vivo cell-cycle analysis showed that LPS challenge
induced cell-cycle activation in the primitive cell subsets
of all genotypes (Figures 2C and 2D). Following LPS,
the fraction of cycling LT-HSC was increased 5-, 2-, andFigure 2. Role of SCA-1 Re-expression, Cell-Cycle Activation, and
(A and B) Lys-GFP reporter mice were challenged with LPS or PBS and t
for Lys-GFP and FCgR expression on GMP, CMP, LSK, LT-HSC, and MPP su
(purple), and Lys-GFP+ (green) cells in LSK (left), LT-HSC (middle), a
(C–E) Analysis of the BM after 24 hr of LPS or PBS challenge in WT, TR
showing S phase (as bromodeoxyuridine incorporation) and G0/G1 ph
LSK distribution in S phase and G0 phase (n = 16–20). (D) Bar graphs s
(n = 7–10). (E) Bar graphs show the percentage of annexin V+ cells i
Data represent mean ± SEM. LPS versus PBS: *p < 0.05, **p < 0.01; W
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Interestingly, cycling of MYD88/ and TRIF/ HSPC
was increased in a similar manner following LPS, despite
their different expansion responses. Cell-cycle activa-
tion induced by LPS was associated with an increase in
apoptosis, which was more noticeable in WT cells; similar
rates of apoptosis in response to PBS and LPS were observed
in MPP cells in all genotypes (Figure 2E).
Loss of MYD88 Rescues LPS-Induced
Myelosuppression
Consistent with our previous results (Rodriguez et al.,
2009), acute exposure to P. aeruginosa LPS caused a signifi-
cant reduction of BM CMP, GMP, and GR1+MAC1+ subsets
without affecting CLP (Figures 3A–3E, S3A, and S3B). Strik-
ingly, loss of MYD88, but not TRIF, prevented reduction of
these subsets (Figures 3C–3E). Myeloid progenitors showed
modest changes in the cell cycle following LPS (Figure S3C).
Apoptosis was significantly increased in WT CMP, GMP,
and GR1+MAC1+ cells whereas it was modestly augmented
inMYD88/ and TRIF/ CMP, and negligible in the GMP
cell populations (Figure S3D). These results suggest that the
protective effect of MYD88 deficiency on myelosuppres-
sion cannot be explained simply by reduced apoptosis
and/or increased cell cycle, and that other mechanisms
contribute to this process.
These effects were also recapitulated in amouse model of
bacterial sepsis. Similarly to what was observed upon LPS
administration, myeloid progenitors and mature myeloid
cells were dramatically reduced during CLP-induced perito-
nitis; this effect was prevented by loss of MYD88, but not
loss of TRIF (Figure 3F). Collectively, these data show that
activation of the TLR4-MYD88 pathway plays a dominant
role in mediating myeloid suppression during endotoxe-
mia and sepsis.
Cell-Autonomous and Non-Cell-Autonomous Effects
of TRIF and MYD88 on HSC and Myeloid Progenitors
during Sepsis
In addition tomechanisms intrinsic to hematopoietic cells,
the microenvironment regulates hematopoiesis through
inflammatory cytokines secreted by non-hematopoietic
cells (van Lieshout et al., 2012). Thus, we evaluated theCell Survival in LSK Expansion following LPS
heir BM analyzed by FACS at 24 hr. (A) Representative density plots
bsets in the BM. (B) Absolute number per femur of total (red), FCgR+
nd MPP (right) subsets (n = 3–4).
IF/, and MYD88/ mice. (C) Representative contour plots (left)
ase for the LSK population. Bar graph (right) indicates the mean
how the percentage of cells in S phase in LT-HSC, MPP1, and MMP2
n LSK, LT-HSC, MPP1, and MMP2 (n = 3–5).
T versus MYD88/ or TRIF/: ^^ p < 0.01.
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Figure 3. LPS and Sepsis Induce BM Myeloid Suppression in an MYD88-Dependent Manner
Immunophenotypic analysis of BM cells was conducted by FACS on WT, MYD88/, and TRIF/mice 24 hr after challenge with LPS or PBS,
or CLP surgery.
(A) Representative contour plots of myeloid progenitor populations labeled with the progenitor markers (CMPs: LinIL-7RaSCA-1
c-KIT+CD34+FCgRlo; GMPs: LinIL-7RaSCA-1c-KIT+CD34+FCgRhi; MEPs: LinIL-7RaSCA-1c-KIT+CD34FCgRlo).
(B) Representative contour plots of mature myeloid GR1+MAC1+ cells.
(legend continued on next page)
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role of tumor necrosis factor a (TNF-a), granulocyte col-
ony-stimulating factor (G-CSF), and IFN-a, cytokines that
are consistently upregulated during infections by LPS
(Boettcher et al., 2014; Weighardt and Holzmann, 2007).
The effects of LPS on BM LSK and GR1+MAC1+ pools
were recapitulated by in vivo injection of recombinant
TNF-a (Figure S4A) and were IFN type I independent, as
shown by the impact of LPS stimulation in Ifnar1/ mice
(Figure S4B). Following LPS challenge, MYD88/ mice
were defective in production of G-CSF and TNF-a, whereas
TRIF/mice were defective only in TNF-a production (Fig-
ure S4C). While IFN-a serum levels were greatly induced by
polyinosinic:polycytidylic acid (pIpC), they were modestly
upregulated by LPS inWTmice andwere close to normal in
both MYD88/ and TRIF/ mice, despite their different
responses to LPS (Figure S4D). Thus, in TRIF/ mice LPS-
induced myelosuppression still occurs despite low levels
of TNF-a and IFN-a, and LPS-induced LSK expansion is
abrogated despite high levels of G-CSF, suggesting that
additionalmechanisms contribute to this complex process.
To dissect the relative contribution of cell-autonomous
and non-cell-autonomous mechanisms mediated by
MYD88 and TRIF, we established two BM chimeric mouse
models: (1) CD45.2+ TRIF/ orMYD88/ BM donor cells
engrafted into CD45.1+WT recipient mice, and vice versa;
and (2) mixed chimeras: CD45.2+ WT-GFP BM cells mixed
1:1 with CD45.2+ TRIF/ or MYD88/ cells engrafted
into CD45.1+ WT recipient mice (Figure S4E). These
mice were challenged with LPS at 8–10 weeks after
transplantation, when donor cells were fully engrafted
(>80%, data not shown). Analysis of the HSC populations
in the reciprocal chimeras showed that loss of TRIF was
protective when it was occurring in either the hematopoi-
etic cells or the microenvironment (Figure 4A). The mixed
chimeras confirmed that the hematopoietic-restricted
effect observed in TRIF/ LT-HSC and MPP was cell
intrinsic and not due to soluble factors secreted byWT he-
matopoietic cells acting in trans (Figure 4B and scheme in
Figure 4F). As expected, loss of MYD88 did not affect HSC
expansion in any of the chimeras (Figures 4B and S4F). In
contrast, loss of MYD88, but not of TRIF, protected GMP
and GR1+MAC1+ cells from the effects of LPS, when it
was occurring both in the hematopoietic cells and in the
microenvironment (Figures 4C and 4D). Experiments
conducted with the mixed chimeras demonstrated that
the protection conferred to GR1+MAC1+ cells by MYD88
deletion was abolished in the presence of WT hemato-(C–E) Average frequency (top) of CMP (C) and GMP (D) in the gated Lin
average absolute cell number per femur of each subset (bottom) in P
(F) Bar graphs indicate the mean of absolute number of CMP, GMP, and
mice (WT and MYD88/: n = 6–10; TRIF/: n = 3).
Data represent mean ± SEM. LPS versus PBS: *p < 0.05, **p < 0.01; W
946 Stem Cell Reports j Vol. 6 j 940–956 j June 14, 2016poietic cells. This indicates that factors secreted by
hematopoietic cells acting in trans contributed to the he-
matopoietic-restricted effect of MYD88 on GR1+MAC1+
cells (Figures 4E and 4F).
Distinct Impact of MYD88 and TRIF on Myeloid
Progenitor Differentiation
Direct LPS stimulation of Lin cells in vitro resulted in
expansion of LSK cells and decreases in myeloid progeni-
tors and GR1+MAC1+ cells (Figures 5A and S5A). This
confirmed the contribution of a hematopoietic-restricted
mechanism that was microenvironment independent.
Comparative analysis of Tlr4, Trif, and Myd88 showed a
comparable pattern of expression in WT LSK, CMP, GMP,
and GR1+MAC1+ subsets (Figure S5B), suggesting that the
differential impact of TRIF and MYD88 on various BM sub-
sets is independent of their relative expression level, and
likely due to the different cell context. To further investi-
gate differences exhibited by the WT, MYD88/, and
TRIF/ myeloid progenitors during sepsis, we examined
their ability to differentiate in vitro after in vivo exposure
to LPS. CMP and GMP subsets were sorted from each geno-
type following PBS or LPS challenge and grown in vitro in
conditions favoring myeloid differentiation. Sorted CMP
fromLPS-challengedWTand TRIF/mice exhibited defec-
tive differentiation into GR1+MAC1+ cells compared with
CMP from PBS controls. In contrast, CMP from LPS-treated
MYD88/ mice differentiated similarly to PBS controls
(Figure 5B). Differentiation of GMPs into GR1+MAC1+ cells
was similar in both conditions (Figure 5C). These data show
that in response to LPS, activation of MYD88, but not TRIF,
impairs CMP differentiation into GR1+MAC1+ cells.
Loss of TRIF Protects HSC from the Exhaustion
Induced by Endotoxemia
Bacterial sepsis causes dysfunctional expansion of HSPC
followed by their exhaustion and inability to reconstitute
recipients over short and long terms (Rodriguez et al.,
2009). As the loss of TRIF, but not MYD88, prevented
expansion of immunophenotypic HSPC following LPS
challenge or sepsis, we investigated whether loss of TRIF
could also prevent the HSC exhaustion observed in trans-
plantation assays. CD45.2+ LSK cells (n = 2,500) sorted
from the BM of PBS- or LPS-challenged WT, MYD88/,
or TRIF/ mice were transplanted into lethally irradiated
CD45.1+ recipients together with 105 whole BM compet-
itor cells (CD45.1+). PBS LSK pools containing comparable population and of GR1+MAC1+(E) in the total BM population, and
BS- versus LPS-challenged mice (n = 5–14).
GR1+MAC1+ per femur in mice subjected to CLP- versus sham-treated
T versus MYD88/ or TRIF/: p^ < 0.05, ^^ p < 0.01.
***
A
0
0.4
0.8
1.2
1.6
2.0 LT-HSC
%
 o
f L
in
-
C
el
ls
Parental          WT        TRIF-/-
Donor WT       TRIF-/- WT
Recipient WT         WT TRIF-/-
0
5
10
15
20
25
30 MPPs
%
 o
f L
in
-
C
el
ls PBS
LPS
Parental          WT        TRIF-/-
Donor WT       TRIF-/- WT
Recipient WT         WT TRIF-/-
WT-GFP/WT PBS 
WT-GFP/WT LPS 
KO/WT PBS 
KO/WT LPS 
B
0
0.25
0.50
0.75
1.00
1.25
1.50
1.75
2.00 LT-HSC
%
 o
f L
in
-
C
el
ls *
* *
Donor           WT-GFP MYD88-/- WT-GFP  TRIF-/-
Recipient WT
*
0
1
2
3
4
5
6
7
20
25
30 MPPs
%
 o
f L
in
-
C
el
ls
*
*
Donor           WT-GFP MYD88-/- WT-GFP  TRIF-/-
Recipient WT
C
Parental       PBS   WT KO  - - WT KO  - - WT KO  - - WT KO  - -
Donor             - - - KO WT - - KO WT     - - KO WT       - - KO WT
Recipient        - - - WT KO       - - WT KO      - - WT KO       - - WT KO 
0
20
40
60
80
100
120
CMP GMP CMP GMP
MYD88-/- LPS 
%
 o
f P
B
S
D GR1+MAC1+
PBS
LPS
0
5
10
15
20
25
30
35
**
**
**
%
 o
f C
el
ls
Parental          WT        MYD88-/-
Donor                                             MYD88-/- WT
Recipient                                           WT         MYD88-/-
**
**
** **
E GR1+MAC1+
0
10
20
30
40
50
MYD88-/- TRIF-/-
%
 o
f G
r1
+ M
ac
1+
 C
el
ls
WT-GFP/WT PBS
KO/WT LPS
WT-GFP/WT LPS
** ** **
**
TRIF-/- LPS 
^
^
^ ^^
^
^
^^
^^ ^
*
*
F
Figure 4. Cell-Autonomous and Non-cell-autonomous Roles of TRIF and MYD88 in LPS-Induced HSC Expansion and Myelosup-
pression
(A) Chimeras: WT recipients of TRIF/ donor cells, TRIF/ recipients of WT donor cells, and WT recipients of WT cells were challenged
with LPS or PBS and analyzed after 24 hr (n = 4). WT and TRIF/ mice (parental) were used as a reference (n = 11). Bar graph shows the
mean percentage of LT-HSC and MPPs in the Lin population.
(B) WT recipients (CD45.1) were transplanted with WTGFP+ + MYD88/ BM cells or WTGFP+ + TRIF/ BM cells, mixed 1:1 ratio. After
8 weeks mice were challenged with LPS or PBS for 24 hr. Bar graphs show the mean percentage of LT-HSC and MPPs in gated WTGFP+ donor
cells (light and dark gray bars, n = 4) and in gated GFP (CD45.2) KO donor cells (red and black bars, n = 4) within the same recipient.
(legend continued on next page)
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numbers of LT-HSC (range 400–512) and MPP (range
1,351–1,391) in all genotypes engrafted equally well over
short and long terms (70% chimerism at 24 weeks; Fig-
ure 6A, left panel). In contrast, LPS LSK pools from WT,
MYD88/, and TRIF/ mice containing a comparable
number of LT-HSC (range 211–229) and MPP (range
1,665–1905) displayed significant differences in their abil-
ity to compete and engraft over the short and long terms
(Figure 6A, right panel). The engraftment ability of LPS
WT LSK was poor over both short and long terms: chime-
rism ranged from 10% at week 8 to 15% at week 24. Impor-
tantly, low engraftment of septic WT cells was not due to
decreased homing (Figure 6B). This indicates that despite
LT-HSC numbers were not significantly perturbed, and
MPP numbers were increased after LPS, their short- and
long-term ability to reconstitute hematopoiesis was
severely impaired. In contrast, LPS-treated TRIF/ LSK
cells showed significantly improved short-term engraft-
ment (51% chimerism at week 8), and fully restored
long-term reconstitution at 24 weeks (68% chimerism;
Figure 6A). LPS MYD88/ LSK cells showed engraftment
between that of LPSWTand TRIF/ LSK cells (22% chime-
rism at week 8 and 35% at week 24).
Analysis of total BM at week 24 after transplantation
showed that LPS LSK from WT donor mice contributed
only to 35% of all recipients’ BM, whereas LPS LSK from
MYD88/ and TRIF/ donors contributed to 47% and
73%, respectively (Figure 6C). Moreover, the contribution
of LPS TRIF/ LSK donor cells to the total recipient LSK
pool was similar to that of PBS TRIF/ LSK donor cells,
indicating complete protection by TRIF deletion (Fig-
ure S6D). Analysis of primitive subpopulations showed a
low contribution ofWTandMYD88/ LPS LSK donor cells
to LT-HSC, MPP1, and MPP2 subsets (ranging from 13% to
38%), whereas TRIF/ LPS LSK donor cells contributed
60%–80% to all the primitive subsets (Figure 6D).
Next, we measured the impact of acute exposure to
LPS on LT-HSC self-renewal. Absolute numbers of donor(C) Bar graph shows the percentage of CMP and GMP in LPS- versus PB
cells, TRIF/ and MYD88/ recipients of WT cells, and in parental
n = 4–6.
(D) WT recipients of MYD88/ donor cells, MYD88/ recipients of W
with LPS or PBS and analyzed after 24 hr. Bar graph shows the mean
(E) WT recipients (CD45.1) were transplanted with WTGFP+ + MYD88
8 weeks mice were challenged with LPS or PBS for 24 hr. Bar graphs sho
cells (WT; n = 4) and in gated GFP (CD45.2) KO donor cells (KO, n = 4)
challenged with PBS (n = 8).
(F) LPS activation of TLR4-MYD88 or -TRIF signaling exerts its effects o
(1) microenvironment-dependent: activation of MYD88 in the BM st
matopoietic-restricted: activation of MYD88 in HC stimulates the rele
cell-intrinsic (or cell-autonomous): activation of TRIF in the HC caus
Data represent mean ± SEM. LPS versus PBS: *p < 0.05, **p < 0.01; W
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transplantation and compared with absolute numbers of
LT-HSC in parental mice used as donors (input control;
Figure 6E). PBS LT-HSCs fromWT, MYD88/, and TRIF/
donors maintained a similar regeneration potential at
24 weeks after transplantation and reached total numbers
similar to those of each parental mouse. In contrast,
LPS-treated WT donor LT-HSC exhibited significantly
fewer numbers compared with input control (5-fold
decrease), but LPS-treated TRIF/ LT-HSC showed a ca-
pacity of regeneration similar to PBS-treated TRIF/ LT-
HSC. LPS-treated MYD88/ LT-HSC showed intermediate
regeneration potential. Calculation of the LT-HSC self-
renewal quotient, as previously described (Challen et al.,
2012), showed that it was greatly decreased in LPS WT
LT-HSC, but was highly preserved in LPS TRIF/ LT-HSC
(Figure 6F). In conclusion, these results show that LPS
exposure results in qualitative damage to LT-HSC and
MPP, and that loss of TRIF protects LT-HSC self-renewal
and MPP functions during acute stress.
Impact of Endotoxic Injury on Multilineage
Reconstitution and Expression of Key Regulators of
HSC Transcriptional Programs
We examined whether LPS alters the ability of HSCs to
replenish all hematopoietic lineages and whether MYD88
and/or TRIF deficiency has an impact on this function.
WT donor-derived LPS HSC differentiated less into CMP,
GMP, megakaryocyte-erythrocyte progenitor (MEP), CLP,
and GR1+ subsets compared with control PBS HSC (6%–
25% overall; Figures 7A and S7A). However, TRIF deficiency
rescued the ability of LPS LSK cells to differentiate into
these subsets: LPS TRIF/ donor cells contributed to up
to 70% of CMPs, GMPs, and MEPs, 68% of CLPs, and
73% of GR1+ subsets. MYD88 deficiency showed some pro-
tection, as seen by an increased contribution to CMPs and
GMPs (up to 40%), to CLPs and MEPs (up to 27%), and to
GR1+ cells (up to 56%; Figures 7A and S7A).S-treated mice: in chimeras WT recipients of TRIF/ or MYD88/
WT, MYD88/, and TRIF/ mice. Parental, n = 8–19; chimeras,
T donor cells, and parental WT and MyD88/ mice were challenged
percentage of GR1+MAC1+ cells in total BM cells (n = 8–17).
/ BM cells or WTGFP+ + TRIF/ BM cells, mixed 1:1 ratio. After
w the mean percentage of GR1+MAC1+ cells in in gated WTGFP+ donor
within the same recipient. PBS controls are WT-GFP+ of all chimeras
n hematopoietic cells (HC) through direct and indirect mechanisms:
roma cells results in the release of factors that act on HC; (2) he-
ase of factors affecting neighboring HC in a paracrine fashion; (3)
es a direct effect on the cell.
T versus MYD88/ or TRIF/: p^ < 0.05, ^^ p < 0.01.
AC
B
32.58.12
3.99
11.46.84
6.42
41.39.31
3.84
41.88.51
5.78
32.66.42
7.89
8.951.37
8.68
LPS
PBS
MAC-1
G
R
-1
WT MYD88-/- TRIF-/-
%
 G
r1
+ /
M
ac
1+
CMP Differentiation
0
20
40
60
80
100
WT MYD88-/- TRIF-/-
*
PBS
LPS
0
20
40
60
80
100
WT MYD88-/- TRIF-/-
%
 G
R
1+
/M
A
C
1+
GMP Differentiation
PBS
LPS
LPS
PBS
MAC-1
G
R
-1
76.01.23
8.07
72.71.26
17.7
65.52.19
9.95
65.24.06
9.02
80.54.63
6.17
85.82.95
5.10
WT MYD88-/- TRIF-/-
0
5
10
15
20
25
30
PBS LPS
MP
%
 o
f L
in
-
C
el
ls
0
5
10
15
20
25
30
35
PBS LPS
LSK
%
 o
f L
in
-
C
el
ls
**
0
5
10
15
20
25
30
35
PBS LPS
GR1+MAC1+
%
 o
f C
el
ls
**
PBS
LPS
^^ ^^
Figure 5. Loss of MYD88 but Not TRIF Preserves Myeloid Differentiation
(A) Purified Lin cells were cultured with PBS or LPS in vitro and analyzed 12 hr later. Bar graphs show the percentage of LSK, MP (CMP +
GMP) in Lin cells, and GR1+MAC1+ in total alive cells (n = 6).
(B and C) CMP and GMP subsets were sorted from WT, TRIF/, and MYD88/ mice exposed to LPS or PBS for 24 hr. Sorted cells were
cultured in vitro in myeloid differentiation conditions. Representative contour plots (left) and average percentage (right) of GR1+MAC1+
cells generated from CMPs at day 4 (B) and from GMPs at day 2 (C) (n = 3–4).
Data represent mean ± SEM. LPS versus PBS: *p < 0.05, **p < 0.01; MYD88/ versus WT or TRIF/: ^^ p < 0.01.Analysis of multilineage reconstitution in peripheral
blood was consistent with these observations. LPS WT
HSC showed a very low contribution to myeloid, B, and
T cells at early and late time points. Although overall line-
age distribution was not significantly affected, contribu-tion to the myeloid lineage was relatively more compro-
mised in the short term (8 weeks; Figures 7B and S7B),
suggesting an impairment of MPP to readily generate
myeloid progenitors, as previously observed (Rodriguez
et al., 2009). LPS TRIF/ HSC contributed robustly to allStem Cell Reports j Vol. 6 j 940–956 j June 14, 2016 949
three lineages at every time point examined (early, 28%–
63%; late, 43%–78%), and MYD88/ LPS HSC showed
intermediate engraftment potential, with progressive im-
provement over time (early, 19%–45%; late, 30%–47%).
To gain further insight into downstream events associ-
ated with altered myeloid differentiation and HSC func-
tions during sepsis, we evaluated the expression of two
transcription factors critical for HSC and myeloid differ-
entiation programs: PU.1 (encoded by Spi1) and C/EBPa
(encoded by CebpA). qPCR analysis of sorted BM subsets af-
ter LPS showed a dramatic decrease in Spi1 transcripts in
WT and TRIF/ LSK cells, but not in MYD88/ LSK cells
(Figure 7C left). Analysis of PU.1 expression following
LPS in the Spi1-GFP reporter mice confirmed its downregu-
lation in LT-HSC andMPP and, in particular, in committed
progenitors (Figures S7C–S7E). Similarly, CebpA expression
was significantly decreased in WT LSK cells following LPS
challenge, but remained unaffected in the absence of
MYD88 or TRIF (Figure 7C right). Of note, persistence of
normal levels of Spi1 and CebpA expression correlated
withmaintenance ofmyeloid differentiation inMYD88/
mice during LPS endotoxemia.
AsHSC exposed to LPS showeddecreased short- and long-
term ability to engraft and differentiate (Figures 7A, 7B, and
S7B), we investigated whether changes in Spi1 and CebpA
levels observed in response to LPS persisted after transplan-
tation. LPS WT LSK cells sorted at 24 weeks after transplan-
tation exhibited lower expression of both Spi1 and CebpA
compared with WT PBS LSK cells. In contrast, MYD88/
and TRIF/ LPS LSK cells maintained levels of Spi1 and
CebpA expression similar to those of PBS LSK controls
(Figure 7D). Collectively, these data suggest that acute LPS
exposure leads to long-lasting downregulation of key tran-
scription factors required forHSCmaintenanceandmyeloid
differentiation. Loss of TRIF and/or MYD88 partially pre-
vented such disruptions, indicating their association with
transcriptional programs regulated by PU.1 and C/EBPa.DISCUSSION
TLR4 activation via MYD88 or TRIF pathways plays a cen-
tral role in regulating host defense against bacterial infec-
tion (Poltorak et al., 1998; Beutler, 2000; Weighardt and
Holzmann, 2007). However, the specific contribution of
MYD88 and TRIF in regulating the BM response to sepsis
is poorly understood. In this study, we dissected these
two pathways using knockout mice lacking MYD88 or
TRIF function in combination with P. aeruginosa LPS-
induced endotoxemia (Rodriguez et al., 2009) or CLP-
induced peritoneal polymicrobial sepsis (Ferreira et al.,
2014). Our observations unveil two distinct mechanisms
mediating the effects of severe sepsis on BM homeostasis.950 Stem Cell Reports j Vol. 6 j 940–956 j June 14, 2016MYD88 activation is critical for myelosuppression occur-
ring in BM during sepsis, whereas TRIF activation mediates
permanent injury of HSC (Figure 7E).
Basedonourpreviousfindings (Rodriguez et al., 2009),we
initially hypothesized that the myelosuppression occurring
during sepsis was caused by dysfunctional expansion of
HSPC (LSK) associated with a block of differentiation and
inability to produce adequatemyeloid precursors. However,
our studies using MYD88/ and TRIF/mice suggest that
myelosuppression and HSPC dysfunction can occur as two
independentprocesses. Analysis of BMresponse toLPS chal-
lengeor severe sepsis showed that TRIF deficiencyprevented
LSK expansion, but not the loss of myeloid progenitors. In
contrast, MYD88 deficiency preserved myeloid cells but
did not abolish the LSK expansion. This suggests that TRIF
andMYD88 have cell-specific effects.
Following LPS or sepsis CMP and GMP pools are rapidly
depleted, resulting in decreased output of GR1+MAC1+
cells, an effect largely prevented by loss of MYD88 but
not of TRIF. Differences in cell cycle and apoptosis of
myeloid progenitors in the three genotypes did not
sufficiently account for differences in outcome. Indeed,
we observed that CMP’s ability to differentiate into mature
GR1+MAC1+ cells was severely impaired following in
vivo exposure to LPS, and that this effect was MYD88
dependent. Reciprocal transplants showed that deletion
of MYD88 prevented myelosuppression by the combi-
natorial effect of microenvironment-dependent and -inde-
pendent mechanisms (hematopoietic-restricted). Mixed
chimera experiments demonstrated that the hematopoi-
etic lineage-restricted effect of MYD88 on GR1+MAC1+
cells is mediated by secondary factor(s) produced by
hematopoietic cells and acting in trans on myeloid
cells. It is likely that cytokines such as TNF-a, INFs, and
G-CSF contribute to MYD88-dependent myelosuppression
following LPS. In vivo inoculation of recombinant TNF-a
reduced GR1+MAC1+ cells in a manner similar to that un-
der LPS challenge. However, GR1+MAC1+ cell production
following LPS was severely hampered in TRIF/ and
Ifnar1/ mice despite a low level of TNF-a and dampened
IFN-a response, suggesting as yet unidentified additional
players contributing to this process.
Thus, whereas MYD88 has a protective effect in chronic
inflammation (Boettcher et al., 2014), it has an adverse
effect on myeloid cells during severe sepsis (see notes in
Figure S4).
As previously reported (Rodriguez et al., 2009), we
observed a significant expansionof immunophenotypically
defined LSK cells following LPS stimulation or CLP-induced
peritonitis. This increase in the LSK subsetwasmostly due to
expansion of the MPP pool. A modest increase in LT-HSC
numbers was observed when LT-HSC were defined as LSK
CD150+CD48 (used for this study), while there was a
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Figure 6. Loss of TRIF Preserves Long-Term Engraftment and Stem Cell Self-Renewal after Acute LPS Exposure
(A and C–E) 2,500 LSK cells sorted from PBS- or LPS-challenged WT, MYD88/ and TRIF/ mice (CD45.2+) were transplanted into
recipient BoyJ (CD45.1+) and monitored for up to 24 weeks.
(A) Left: PBS LSK (400–500 LSKCD150+CD48) donor cell engraftment (CD45.2+) in the peripheral blood. n = 8–12. Right: LPS LSK (200
LSKCD150+CD48) donor cell engraftment (CD45.2+) in the peripheral blood. WT, n = 5–14; MyD88/, n = 6–12; TRIF/, n = 7–8.
(legend continued on next page)
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significant increase when LT-HSC were defined as LSK
FLK2CD34, likely for the greater inclusion of MPP.
However, no changes were noticed when a more stringent
LT-HSC definition was used (Oguro et al., 2013). We docu-
mented some contamination of the MPP pool by SCA-1-
negative progenitors re-expressing SCA-1, as observed in
HSC following pIpC (Pietras et al., 2014). However, this fac-
tor contributed only in part to the overall MPP expansion
induced by LPS. In addition, surface expression of SCA-1
was not significantly increased in LT-HSC but was signifi-
cantly upregulated inMPP. Thus, it is possible that primitive
progenitors upregulate and prolong SCA-1 expression as
part of the physiologic reaction to sepsis, as SCA-1 is also
involved in maintaining HSPC function (Bradfute et al.,
2005; Essers et al., 2009). The abnormal MPP expansion
and SCA-1 upregulation induced by LPS was prevented by
loss of TRIF, but not of MYD88, and the mixed chimera
experiment showed that this effect is cell intrinsic.
Taken together, our data indicate that a balance between
increased cell-cycle activation and increased apoptotic
rates seems to account for maintenance of similar numbers
of LT-HSC in LPS-treated mice and controls in all geno-
types, although both processes were more intense in WT
than inMYD88/ or TRIF/mice. In contrast, differences
in cell cycle, apoptosis, and progenitor cell contamination
observed in the MPP pools do not sufficiently explain the
significant MPP expansion in WT and MYD88/ and the
lack of it in TRIF/ mice. It is possible that MPP commit-
ment/differentiation is affected by LPS, and that a slow
egression of MPP from the primitive to the differentiated
cell pool (retention) also contributes to the expansion. As
discussed later, this possibility is supported by the finding
that critical transcription factors are altered in these cells
and that they contribute poorly to short-termmultilineage
reconstitution after transplantation.
HSC functions are severely compromised following acute
and chronic TLR4 activation (Esplin et al., 2011; Rodriguez
et al., 2009). We demonstrated that TRIF signaling is a crit-
ical mediator of HSC injury, since its deletion fully restores(B) Percentage of CD45.2+ cells in the BM of CD45.1+ BoyJ mice 16 hr
WT (CD45.2+) mice (n = 3).
(C) Percentage of donor engraftment of WT, MYD88/, and TRIF/ P
post transplantation (n = 7–9).
(D) Percentage of donor-derived CD45.2+ BM LT-HSC, MPP1, and MPP
(E) Absolute number of donor-derived LT-HSC per femur: in WT, MY
transplants (parental); at 24 weeks in transplanted recipients of sort
cells from LPS-challenged mice (TR-LPS). n = 7–9.
(F) Self-renewal quotients of LT-HSC cells from PBS- and LPS-challe
plantation. Quotient is calculated by dividing the absolute number of
time of transplantation. n = 7–9.
Data were from two independent experiments and represent mean ± S
TRIF/: p^ < 0.05, ^^ p < 0.01. n.s., not significant.
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of LPS LSK cells containing equal amounts of LT-HSC in
WT, MYD88/, and TRIF/ mice revealed significant dif-
ferences in long-term engraftment of these genotypes. WT
LT-HSC from mice challenged with LPS were significantly
exhausted at 24weeks after transplant and showed low abil-
ity to self-renewandcontribute toall lineages incompetitive
repopulation assays. In contrast, LPS TRIF/ LT-HSCmain-
tained their self-renewal and multilineage contribution,
similarly to PBS controls. Loss of MYD88 provided some
protection to HSC and progenitors, as LPS MYD88/ LSK
cells exhibited better engraftment than the LPS WT LSK
cells, but did not fully rescue their functions. Interestingly,
enrichment in MPP and contaminating progenitors in the
LSK pool did not confer any advantage in short-term
engraftment of WT and MYD88/ LSK donor cells.
Collectively, our results show that HSC are qualitatively
damaged by TRIF activation during LPS exposure and that
this damage persists over the long term, and also in the pres-
enceof ahealthymicroenvironment. Strikingly, TRIF activa-
tion, unlike MYD88, did not directly cause myelosuppres-
sion. This cell-context-dependent effect does not seem to
be mediated by differential expression of MYD88 or TRIF
in the different subsets. Similar to the cell-context-depen-
dent impact of other molecules (i.e., Notch), the distinct
effects of TRIF andMYD88are likelydue todifferent require-
ments andmolecular interactions of these two pathways in
HSC and in myeloid progenitors. Potential mechanisms
downstream of TRIF in HSC may involve STAT1, AKT, p38/
ROS (Katsoulidis et al., 2005), or pathways activated by
type I IFNs, which are known to damage HSC by induction
of cell-cycle entry, apoptosis, and DNA damage (Baldridge
et al., 2010; Pietras et al., 2014). However, mild induction
of IFNs by LPS and lack of a protective effect in Ifnra1/
mice following LPS suggest that this mechanism is not
dominant in an LPS response.
Analysis of expression of Spi1 and CebpA, two key
transcription factors involved in the regulation of HSC
and myeloid transcriptional programs (Hasemann et al.,after receiving 25,000 LSK cells sorted from LPS- or PBS-challenged
BS or LPS LSK cells (CD45.2+) in the BM of recipient mice at 24 weeks
2 subsets in recipient mice (n = 7–9).
D88/, and TRIF/ mice at steady state, prior BM harvest for
ed LSK cells from PBS-challenged mice (TR-PBS); and of sorted LSK
nged WT, MYD88/, and TRIF/ mice at 24 weeks post trans-
LT-HSC at 24 weeks by the average number of LT-HSC input at the
EM. LPS versus PBS: *p < 0.05, **p < 0.01; WT versus MYD88/ or
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Figure 7. Impact of LPS on Multilineage Reconstitution and on of PU.1 and CEBP/a
(A and B) 2,500 LSK cells sorted from PBS- or LPS-challenged WT, MYD88/, and TRIF/mice (CD45.2+) were transplanted into recipient
BoyJ (CD45.1+). Recipients were monitored for up to 24 weeks.
(A) Percentage of donor-derived CD45.2+ BM CMP (left), GMP (middle), and GR1+ (right) in recipient mice at week 24 (n = 7–9).
(B) Line graphs show mean percentage of donor CD45.2+ cells in in myeloid cells (GR1+), B cells (B220+), and T cells (CD4+ or CD8+) in
peripheral blood of recipient mice after transplantation (n = 7–16).
(C) Relative mRNA expression level of Spi1 and CebpA in LSK cells sorted from WT (n = 5–9 samples), MYD88/ (n = 4–5 samples), and
TRIF/ (n = 3 samples) mice challenged with PBS or LPS for 24 hr; each sample derived from cells pooled from 2–3 mice; minimum of three
independent experiments.
(D) WT, MYD88/, and TRIF/ LSK cells were sorted at 24 weeks after transplantation. Fold change of expression level of Spi1 and CebpA
(n = 3–4 samples derived from cells pooled from 2–3 mice).
(legend continued on next page)
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2014; Staber et al., 2013), revealed that they were signif-
icantly downregulated in WT HSPC following LPS treat-
ment, while their levels were preserved in the absence
of MYD88 (Spi1) or TRIF (CebpA). Spi1 and CebpA expres-
sion levels continued to remain low in HSCs at 24 weeks
following transplant, whereas they were restored in
MYD88/ and TRIF/ HSPC. Thus, our study shows
that acute exposure of HSPC to LPS endotoxemia is suf-
ficient to induce permanent transcriptional changes
even when the endotoxic environment is removed and
cells are transplanted in healthy donors. Changes in his-
tone methylation patterns in mature cells have been re-
ported following sepsis (Carson et al., 2011), and we
found changes in epigenetic modifications in HSPC after
in vivo exposure to LPS (H.Z. and N.C., unpublished ob-
servations). Further studies are necessary to address the
impact of epigenetic regulation of HSC on their function
and differentiation during sepsis.
In conclusion, the present study shows that TRIF and
MYD88 uncouple effects of TLR4 signaling on HSC and
myeloid progenitors during severe bacterial infection.
This observation has potential clinical relevance. Despite
the central role for TLR4 in sepsis, a recent randomized
clinical trial failed to show survival improvement in pa-
tients with sepsis treated with a TLR4 antagonist (Opal
et al., 2013). It is likely that complete inhibition of TLR4
signaling, with simultaneous inhibition of the MYD88
and TRIF pathway, also abrogates its protective effects,
thus compromising the effectiveness of this therapeutic
approach. The results presented here provide a guide to
further dissect the independent effects of MYD88 and
TRIF during response to severe bacterial infection and
support the rationale for pursuing time-tuned selective
silencing of one pathway (MYD88 or TRIF) to mitigate
myelosuppression or stem cell injury. Finally, these ob-
servations may also provide insight into the impact of
MYD88 and TRIF in HSC and myeloid progenitors during
chronic inflammation related to aging and hematopoietic
cell malignant transformation.EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details on mice,
flow cytometry and cell sorting, cell-cycle and apoptosis analysis,(E) Working model. TRIF and MYD88 uncouple the effects of TLR4-me
during severe sepsis. The role of TLR4 in regulating hematopoiesis in
microbiota maintains a systemic basal state of TLR4 activation. In the
activates: (1) TRIF, leading to injury of LT-HSC (Figure 6) and dysfuncti
re-expressing SCA-1, and impaired egress (Figures 1E, 1F, 2, 7A, and 7
increased apoptosis and impaired differentiation (Figures 3 and 5). Ce
these effects in both pathways (Figure 4).
Data represent mean ± SEM. LPS versus PBS: *p < 0.05, **p < 0.01; W
954 Stem Cell Reports j Vol. 6 j 940–956 j June 14, 2016myeloid progenitor and Lys-GFP in vitro differentiation assay,
and gene expression.
Endotoxemia and Sepsis Models
All animal experiments were approved by the Institutional Ani-
mal Care and Use Committee of the Indiana University School
of Medicine (IUSM). Mice were subjected to intraperitoneal
inoculation of 3 mg/kg P. aeruginosa LPS (Rodriguez et al.,
2009) purchased from Sigma-Aldrich (L8643) and were analyzed
24 hr after challenge. Severe sepsis was induced by CLP using a
21G1 1/2-gauge needle, as described by Ferreira et al. (2014).
Sham mice received cecal ligation but no perforation of the
cecum. Mice were euthanized 24 hr after the CLP surgery for
BM analysis.
Generation of Chimeras
WT/MYD88/ or WT/TRIF/ chimeras were generated by trans-
plantation via tail-vein injection of 2 3 106 BM cells from BoyJ
(CD45.1+) mice into lethally irradiated MYD88/ or TRIF/
(CD45.2+) recipients. MYD88//WT or TRIF//WT chimeras
were generated by transplantation via tail-vein injection of 2 3
106 BM cells from MYD88/ or TRIF/ (CD45.2+) mice into
lethally irradiated BoyJ (CD45.1+) recipients. Mixed chimeras
were generated by using WT cells from the Ubi-GFP mouse
(CD45.2+) as follows. WT, MYD88/, or TRIF/ BM cells
(CD45.2+; 1 3 106 cells) were mixed 1:1 with WT-GFP+
(CD45.2+) BM cells and transplanted into lethally irradiated BoyJ
(CD45.1+) recipients. Engraftment >80% was confirmed in the pe-
ripheral blood 8–10 weeks after transplantation when chimeras
were challenged with LPS or PBS.
Competitive Repopulation Assay
A total of 2,500 LSK donor cells from PBS- or LPS-challenged WT,
MYD88/, and TRIF/ mice (CD45.2+) were sorted and trans-
planted into lethally irradiated BoyJ mice (CD45.1+). A dose of
105 CD45.1+ BM cells were used as competitors. Engraftment
was evaluated in the peripheral blood at 4-week intervals until
week 24. At week 24, all recipients were euthanized for BM
analysis.
Statistical Analysis
Equality of distributions for matched pairs of observations
was tested with Student’s t test. Comparisons were made of
LPS versus PBS and KO versus WT using unpaired t test and
ANOVA when appropriate. Significance in figures is indicated
by *p < 0.05 or p^ < 0.05 and **p < 0.01 or ^^p < 0.01.
Measurements were performed in at least three independentdiated injury on hematopoietic stem cells and myeloid progenitors
homeostatic conditions is still unclear. It is possible that the gut
state of severe sepsis, maximal activation of TLR4 by bacterial LPS
onal expansion of MPPs by cell-cycle activation, shift of progenitors
B); and (2) MYD88, resulting in damage of myeloid progenitors by
ll-autonomous and non-cell-autonomous mechanisms contribute to
T versus MYD88/ or TRIF/: p^ < 0.05, ^^ p < 0.01.
experiments. N indicates the number of individual mice used
unless noted otherwise.
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